Industry
Medical - Diagnostics & Research
Intelligent Bio Solutions Inc., a life sciences company, developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. It offers Saliva Glucose Biosensor, an organic thin-film transistor for diabetes management that measures glucose in saliva. The company also focuses on developing SARS-CoV-2 Biosensor, a biosensor test can be used as a complement to the (RNA) virus detection test; and a biosensor platform comprising of biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. The company was incorporated in 2016 and is headquartered in New York, New York. Intelligent Bio Solutions Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.
Loading...
Open
N/A
Mkt cap
N/A
Volume
N/A
High
N/A
P/E Ratio
N/A
52-wk high
N/A
Low
N/A
Div yield
N/A
52-wk low
N/A
Portfolio Pulse from Benzinga Insights
November 08, 2023 | 9:31 pm
Portfolio Pulse from Benzinga Newsdesk
October 24, 2023 | 12:33 pm
Portfolio Pulse from Benzinga Insights
October 20, 2023 | 9:31 pm
Portfolio Pulse from Benzinga Insights
October 17, 2023 | 9:31 pm
Portfolio Pulse from Benzinga Insights
October 10, 2023 | 5:09 pm
Portfolio Pulse from Benzinga Newsdesk
October 05, 2023 | 12:41 pm
Portfolio Pulse from Charles Gross
October 04, 2023 | 9:33 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.